Study Links Citicoline Supplement to Memory Improvements in Older Adults
A recent randomized, placebo-controlled trial has revealed that daily supplementation with citicoline can lead to notable improvements in memory among healthy older adults. The study involved 100 participants aged between 50 and 85, all of whom had demonstrated lower short-term memory scores compared to younger adults, yet were otherwise healthy. Participants were assigned to receive either 500 milligrams of citicoline, specifically in the form of Cognizin, or a placebo every day for a period of 12 weeks. Throughout the trial, participants maintained their usual dietary, exercise, and sleep routines while completing computerized memory and attention assessments at both the start and conclusion of the study.
The results indicated that those in the citicoline group exhibited greater enhancements in episodic memory and an overall memory composite score than those receiving the placebo. Specifically, the citicoline group improved their episodic memory scores significantly, with an average increase of 3.78 points compared to just 0.72 points in the placebo group. However, not all individual memory tests showed improvement; the primary measure of short-term memory for spatial awareness did not surpass the placebo group's results, highlighting mixed outcomes across different memory assessments.
These findings contribute to a growing body of research on citicoline, a compound that the body naturally produces and is available as a dietary supplement. Previous studies have predominantly focused on its effects in individuals with cognitive impairments, making this investigation into healthy older adults particularly noteworthy. The study's design, which included a placebo control, is a standard approach to mitigate the influence of participant expectations on cognitive test outcomes.
Understanding Citicoline's Role in Memory Support for Aging Adults
The trial's duration and participant count align with other short-term studies on citicoline. A systematic review has suggested that while there is some evidence supporting the cognitive benefits of citicoline, most trials have been of limited duration. The researchers noted that episodic memory is particularly susceptible to the effects of aging, with declines typically observed after the age of 60. Citicoline, also referred to as CDP-choline, is essential for the synthesis of phosphatidylcholine, a key component of brain cell membranes. The authors propose that citicoline may bolster the production of this vital fat, which tends to decrease with age, thereby supporting memory function.
Evaluating the Implications of Citicoline Supplementation
Despite the promising results, the study did not address the long-term effects of citicoline supplementation in healthy older adults, nor did it report any serious adverse events during the trial. The article also highlighted that a significant percentage of Americans do not meet daily choline intake recommendations, underscoring the potential importance of citicoline as a dietary supplement. Furthermore, the researchers suggested that combining citicoline with other nutrients, such as creatine, could enhance cognitive performance, although this area requires further exploration.
Overall, while the study provides valuable insights into the potential cognitive benefits of citicoline for older adults, the mixed results and the need for additional long-term research warrant careful consideration. As always, individuals should consult healthcare professionals before beginning any new supplement regimen, especially if they are pregnant, breastfeeding, or taking medications.




